Rare diseases
Investigational molecules
Locations
Back to Germany300 clinical trials in Augsburg, Germany across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes
GermanyStudy on Pelareorep and Atezolizumab for Patients with Advanced or Metastatic Gastrointestinal Cancers
GermanyStudy of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
GermanyStudy Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors
GermanyStudy on Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
GermanyStudy on Venetoclax, Cytarabine, and Mitoxantrone for Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML) Eligible for Intensive Treatment
GermanyStudy Comparing CPX-351 and Conventional Drug Combination for Patients with High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Before Stem Cell Transplant
GermanyStudy on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
GermanyStudy of Pembrolizumab and Lenvatinib for Patients with Advanced Liver Cancer Resistant to Previous Immunotherapy
GermanyStudy on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
GermanyStudy on Guselkumab for Healing in Crohn's Disease Patients
GermanyStudy on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on breast cancer, lung cancer, and lymphoma treatments. Studies evaluating novel therapeutic approaches including targeted therapies and immunotherapy combinations.
Several trials are investigating combination therapies to improve patient outcomes in various cancer types.
Comprehensive research into plaque psoriasis and atopic dermatitis, with multiple trials testing new therapeutic agents and preventive approaches.
Focus on both treatment and prevention strategies for chronic skin conditions.
Innovative studies addressing ulcerative colitis and gastroparesis, testing novel therapeutic approaches and treatment combinations.
Trials aim to improve quality of life and treatment outcomes for patients with chronic digestive conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
